| Ashtin Nichole Mcmurray, DMD | |
|
20326 Main St, Stratford, CA 93266 | |
| (559) 386-4502 | |
| Not Available |
| Full Name | Ashtin Nichole Mcmurray |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 20326 Main St, Stratford, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801417753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 106614 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashtin Nichole Mcmurray, DMD 172 W Sherwood Dr, Hanford, CA 93230-7161 Ph: (559) 707-0466 | Ashtin Nichole Mcmurray, DMD 20326 Main St, Stratford, CA 93266 Ph: (559) 386-4502 |
News Archive
More studies that directly compare the effectiveness of different biologic drugs for rheumatoid arthritis (RA) are needed, say Cochrane Researchers. The researchers reviewed all previous Cochrane Systematic Reviews assessing the effectiveness of biologic disease-modifying drugs for treatment of RA and found that although all were very effective, there was little data on direct comparisons between the drugs that could help doctors decide which to prescribe.
The National Institutes of Natural Sciences, National Institute for Fusion Science and The University of Tokyo Graduate School of Frontier Sciences Department of Advanced Materials Science research group have developed an electron density diagnostic method for atmospheric pressure low-temperature plasma that is anticipated to be applicable for the fields of environmental protection and of medicine and biology.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
To make ends meet, Martha Tapia works 64 hours a week at two Orange County, California, nursing homes. She is one of thousands of certified nursing assistants who perform the intimate and physical work of bathing, dressing and feeding the nation's fragile elderly.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 5 days ago
Dr. Kim Chin-pei Chen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 20326 Main Street, Stratford, CA 93266 Phone: 559-947-3505 Fax: 559-947-3503 |